SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting beta-catenin and epithelial to mesenchymal transition in lung cancer.

Tripathi SK, Biswal BK
Life Sci. 2021 Jul 15;277:119608. doi: 10.1016/j.lfs.2021.119608. Epub 2021 May 11. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.